Cargando…

PB1805: INSIGHTS FROM ORAL AZACITIDINE EARLY ACCESS PROGRAM IN FRANCE: PATIENT POPULATION WITH ACUTE MYELOID LEUKEMIA RECEIVING ORAL-AZA FOR MAINTENANCE OF COMPLETE REMISSION AFTER INDUCTION CHEMOTHERAPY

Detalles Bibliográficos
Autores principales: Raffoux, E., De Botton, S., Ades, L., Carré, M., Cluzeau, T., Saillard, C., Heiblig, M., Beckerich, F., Gastaud, L., Dupuis, A., Richez, U., Dumas, P.-Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429262/
http://dx.doi.org/10.1097/01.HS9.0000850072.95751.61